We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DIA 2021 Annual Meeting: FDA Pilot Program Sees Overwhelming Demand
DIA 2021 Annual Meeting: FDA Pilot Program Sees Overwhelming Demand
The FDA’s three-year-old pilot program on model-informed drug development (MIDD) has attracted more demand from industry than it can accommodate, an agency official said yesterday.